ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cognition-Enhancing Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30C10234
Home | Market Reports | Health| Pharmacy
Global and United States Cognition Enhancing Drugs Market Report Forecast 2022 2028
BUY CHAPTERS

Global Cognition-Enhancing Drugs Market Research Report 2025

Code: QYRE-Auto-30C10234
Report
September 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Accelerated Intelligence
Cognition Therapeutics
Cogstate Ltd
HVMN
Biogen Idec

Cognition-Enhancing Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cognition-Enhancing Drugs Market

Cognition-Enhancing Drugs Market

The global market for Cognition-Enhancing Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cognition-Enhancing Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognition-Enhancing Drugs.
The Cognition-Enhancing Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cognition-Enhancing Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cognition-Enhancing Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cognition-Enhancing Drugs Market Report

Report Metric Details
Report Name Cognition-Enhancing Drugs Market
CAGR 5%
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Accelerated Intelligence, Cognition Therapeutics, Cogstate, HVMN, Biogen Idec
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cognition-Enhancing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cognition-Enhancing Drugs Market report?

Ans: The main players in the Cognition-Enhancing Drugs Market are Accelerated Intelligence, Cognition Therapeutics, Cogstate, HVMN, Biogen Idec

What are the Application segmentation covered in the Cognition-Enhancing Drugs Market report?

Ans: The Applications covered in the Cognition-Enhancing Drugs Market report are Hospital Pharmacies, Drug Stores, Retail Pharmacies

What are the Type segmentation covered in the Cognition-Enhancing Drugs Market report?

Ans: The Types covered in the Cognition-Enhancing Drugs Market report are Oral, Injection

Recommended Reports

CNS & Mental Health

General Pharmaceutical Markets

Neurological Disease Drugs

1 Cognition-Enhancing Drugs Market Overview
1.1 Product Definition
1.2 Cognition-Enhancing Drugs by Type
1.2.1 Global Cognition-Enhancing Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.3 Cognition-Enhancing Drugs by Application
1.3.1 Global Cognition-Enhancing Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.4 Global Cognition-Enhancing Drugs Market Size Estimates and Forecasts
1.4.1 Global Cognition-Enhancing Drugs Revenue 2020-2031
1.4.2 Global Cognition-Enhancing Drugs Sales 2020-2031
1.4.3 Global Cognition-Enhancing Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cognition-Enhancing Drugs Market Competition by Manufacturers
2.1 Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cognition-Enhancing Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cognition-Enhancing Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cognition-Enhancing Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cognition-Enhancing Drugs, Product Type & Application
2.7 Global Key Manufacturers of Cognition-Enhancing Drugs, Date of Enter into This Industry
2.8 Global Cognition-Enhancing Drugs Market Competitive Situation and Trends
2.8.1 Global Cognition-Enhancing Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cognition-Enhancing Drugs Players Market Share by Revenue
2.8.3 Global Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cognition-Enhancing Drugs Market Scenario by Region
3.1 Global Cognition-Enhancing Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cognition-Enhancing Drugs Sales by Region: 2020-2031
3.2.1 Global Cognition-Enhancing Drugs Sales by Region: 2020-2025
3.2.2 Global Cognition-Enhancing Drugs Sales by Region: 2026-2031
3.3 Global Cognition-Enhancing Drugs Revenue by Region: 2020-2031
3.3.1 Global Cognition-Enhancing Drugs Revenue by Region: 2020-2025
3.3.2 Global Cognition-Enhancing Drugs Revenue by Region: 2026-2031
3.4 North America Cognition-Enhancing Drugs Market Facts & Figures by Country
3.4.1 North America Cognition-Enhancing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cognition-Enhancing Drugs Sales by Country (2020-2031)
3.4.3 North America Cognition-Enhancing Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cognition-Enhancing Drugs Market Facts & Figures by Country
3.5.1 Europe Cognition-Enhancing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cognition-Enhancing Drugs Sales by Country (2020-2031)
3.5.3 Europe Cognition-Enhancing Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cognition-Enhancing Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Cognition-Enhancing Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cognition-Enhancing Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Cognition-Enhancing Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cognition-Enhancing Drugs Market Facts & Figures by Country
3.7.1 Latin America Cognition-Enhancing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cognition-Enhancing Drugs Sales by Country (2020-2031)
3.7.3 Latin America Cognition-Enhancing Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cognition-Enhancing Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cognition-Enhancing Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cognition-Enhancing Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cognition-Enhancing Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cognition-Enhancing Drugs Sales by Type (2020-2031)
4.1.1 Global Cognition-Enhancing Drugs Sales by Type (2020-2025)
4.1.2 Global Cognition-Enhancing Drugs Sales by Type (2026-2031)
4.1.3 Global Cognition-Enhancing Drugs Sales Market Share by Type (2020-2031)
4.2 Global Cognition-Enhancing Drugs Revenue by Type (2020-2031)
4.2.1 Global Cognition-Enhancing Drugs Revenue by Type (2020-2025)
4.2.2 Global Cognition-Enhancing Drugs Revenue by Type (2026-2031)
4.2.3 Global Cognition-Enhancing Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Cognition-Enhancing Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cognition-Enhancing Drugs Sales by Application (2020-2031)
5.1.1 Global Cognition-Enhancing Drugs Sales by Application (2020-2025)
5.1.2 Global Cognition-Enhancing Drugs Sales by Application (2026-2031)
5.1.3 Global Cognition-Enhancing Drugs Sales Market Share by Application (2020-2031)
5.2 Global Cognition-Enhancing Drugs Revenue by Application (2020-2031)
5.2.1 Global Cognition-Enhancing Drugs Revenue by Application (2020-2025)
5.2.2 Global Cognition-Enhancing Drugs Revenue by Application (2026-2031)
5.2.3 Global Cognition-Enhancing Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Cognition-Enhancing Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Accelerated Intelligence
6.1.1 Accelerated Intelligence Company Information
6.1.2 Accelerated Intelligence Description and Business Overview
6.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolio
6.1.5 Accelerated Intelligence Recent Developments/Updates
6.2 Cognition Therapeutics
6.2.1 Cognition Therapeutics Company Information
6.2.2 Cognition Therapeutics Description and Business Overview
6.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolio
6.2.5 Cognition Therapeutics Recent Developments/Updates
6.3 Cogstate
6.3.1 Cogstate Company Information
6.3.2 Cogstate Description and Business Overview
6.3.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cogstate Cognition-Enhancing Drugs Product Portfolio
6.3.5 Cogstate Recent Developments/Updates
6.4 HVMN
6.4.1 HVMN Company Information
6.4.2 HVMN Description and Business Overview
6.4.3 HVMN Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 HVMN Cognition-Enhancing Drugs Product Portfolio
6.4.5 HVMN Recent Developments/Updates
6.5 Biogen Idec
6.5.1 Biogen Idec Company Information
6.5.2 Biogen Idec Description and Business Overview
6.5.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biogen Idec Cognition-Enhancing Drugs Product Portfolio
6.5.5 Biogen Idec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cognition-Enhancing Drugs Industry Chain Analysis
7.2 Cognition-Enhancing Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cognition-Enhancing Drugs Production Mode & Process Analysis
7.4 Cognition-Enhancing Drugs Sales and Marketing
7.4.1 Cognition-Enhancing Drugs Sales Channels
7.4.2 Cognition-Enhancing Drugs Distributors
7.5 Cognition-Enhancing Drugs Customer Analysis
8 Cognition-Enhancing Drugs Market Dynamics
8.1 Cognition-Enhancing Drugs Industry Trends
8.2 Cognition-Enhancing Drugs Market Drivers
8.3 Cognition-Enhancing Drugs Market Challenges
8.4 Cognition-Enhancing Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Accelerated Intelligence
Cognition Therapeutics
Cogstate Ltd
HVMN
Biogen Idec
List of Tables
 Table 1. Global Cognition-Enhancing Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cognition-Enhancing Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cognition-Enhancing Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cognition-Enhancing Drugs Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cognition-Enhancing Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cognition-Enhancing Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cognition-Enhancing Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cognition-Enhancing Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cognition-Enhancing Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Cognition-Enhancing Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognition-Enhancing Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cognition-Enhancing Drugs Sales by Region (2020-2025) & (K MT)
 Table 18. Global Cognition-Enhancing Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Cognition-Enhancing Drugs Sales by Region (2026-2031) & (K MT)
 Table 20. Global Cognition-Enhancing Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Cognition-Enhancing Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Cognition-Enhancing Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Cognition-Enhancing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cognition-Enhancing Drugs Sales by Country (2020-2025) & (K MT)
 Table 27. North America Cognition-Enhancing Drugs Sales by Country (2026-2031) & (K MT)
 Table 28. North America Cognition-Enhancing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cognition-Enhancing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cognition-Enhancing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cognition-Enhancing Drugs Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Cognition-Enhancing Drugs Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Cognition-Enhancing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cognition-Enhancing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cognition-Enhancing Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cognition-Enhancing Drugs Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Cognition-Enhancing Drugs Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Cognition-Enhancing Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cognition-Enhancing Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cognition-Enhancing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cognition-Enhancing Drugs Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Cognition-Enhancing Drugs Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Cognition-Enhancing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cognition-Enhancing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cognition-Enhancing Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cognition-Enhancing Drugs Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Cognition-Enhancing Drugs Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Cognition-Enhancing Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cognition-Enhancing Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cognition-Enhancing Drugs Sales (K MT) by Type (2020-2025)
 Table 51. Global Cognition-Enhancing Drugs Sales (K MT) by Type (2026-2031)
 Table 52. Global Cognition-Enhancing Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Cognition-Enhancing Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2020-2025)
 Table 59. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2026-2031)
 Table 60. Global Cognition-Enhancing Drugs Sales (K MT) by Application (2020-2025)
 Table 61. Global Cognition-Enhancing Drugs Sales (K MT) by Application (2026-2031)
 Table 62. Global Cognition-Enhancing Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Cognition-Enhancing Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2020-2025)
 Table 69. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2026-2031)
 Table 70. Accelerated Intelligence Company Information
 Table 71. Accelerated Intelligence Description and Business Overview
 Table 72. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Accelerated Intelligence Cognition-Enhancing Drugs Product
 Table 74. Accelerated Intelligence Recent Developments/Updates
 Table 75. Cognition Therapeutics Company Information
 Table 76. Cognition Therapeutics Description and Business Overview
 Table 77. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Cognition Therapeutics Cognition-Enhancing Drugs Product
 Table 79. Cognition Therapeutics Recent Developments/Updates
 Table 80. Cogstate Company Information
 Table 81. Cogstate Description and Business Overview
 Table 82. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Cogstate Cognition-Enhancing Drugs Product
 Table 84. Cogstate Recent Developments/Updates
 Table 85. HVMN Company Information
 Table 86. HVMN Description and Business Overview
 Table 87. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. HVMN Cognition-Enhancing Drugs Product
 Table 89. HVMN Recent Developments/Updates
 Table 90. Biogen Idec Company Information
 Table 91. Biogen Idec Description and Business Overview
 Table 92. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Biogen Idec Cognition-Enhancing Drugs Product
 Table 94. Biogen Idec Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Cognition-Enhancing Drugs Distributors List
 Table 98. Cognition-Enhancing Drugs Customers List
 Table 99. Cognition-Enhancing Drugs Market Trends
 Table 100. Cognition-Enhancing Drugs Market Drivers
 Table 101. Cognition-Enhancing Drugs Market Challenges
 Table 102. Cognition-Enhancing Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cognition-Enhancing Drugs
 Figure 2. Global Cognition-Enhancing Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cognition-Enhancing Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Cognition-Enhancing Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cognition-Enhancing Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Drug Stores
 Figure 10. Retail Pharmacies
 Figure 11. Global Cognition-Enhancing Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Cognition-Enhancing Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Cognition-Enhancing Drugs Sales (2020-2031) & (K MT)
 Figure 14. Global Cognition-Enhancing Drugs Average Price (USD/MT) & (2020-2031)
 Figure 15. Cognition-Enhancing Drugs Report Years Considered
 Figure 16. Cognition-Enhancing Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Cognition-Enhancing Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Cognition-Enhancing Drugs Players: Market Share by Revenue in Cognition-Enhancing Drugs in 2024
 Figure 19. Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Cognition-Enhancing Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Cognition-Enhancing Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Cognition-Enhancing Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Cognition-Enhancing Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Cognition-Enhancing Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Cognition-Enhancing Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Cognition-Enhancing Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Cognition-Enhancing Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Cognition-Enhancing Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Cognition-Enhancing Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Cognition-Enhancing Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Cognition-Enhancing Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Cognition-Enhancing Drugs by Type (2020-2031)
 Figure 56. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Cognition-Enhancing Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Cognition-Enhancing Drugs by Application (2020-2031)
 Figure 59. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2020-2031)
 Figure 60. Cognition-Enhancing Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Cognitive Enhancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Memory Enhancer Drugs Market Research Report 2024
Global Smart Drugs Market Insights Forecast to 2030
Global Cognitive Diagnostics Market Research Report 2024
Global Flow Enhancer Market Insights Forecast to 2030
Global Memory Impairment Treatment Market Research Report 2025
Global Cognitive Health Supplements Market Research Report 2025
Global Large Animals Drugs Market Insights Forecast to 2030
Global Central Nervous System CNS Stimulant Drugs Market Insights Forecast to 2030
Global Cognitive Decline Market Research Report 2024
Global Cognitive Assessment and Training Healthcare Market Research Report 2025
Global Urology Drugs Market Insights Forecast to 2030
Global Atherosclerosis Drug Market Insights Forecast to 2030
Global Anti erectile Dysfunction ED Drugs Market Insights Forecast to 2030
Global Memory Enhancing Drug Market Insights Forecast to 2030
Global Memory Enhancement Drugs Market Insights Forecast to 2030
Global Alzheimer s Drugs Market Research Report 2025
Global Stroke Treatment Drugs Market Insights Forecast to 2030
Alzheimer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Amnestic Disorders Therapeutic Drugs Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions